Biomica ^Company

Biomica is an emerging biopharmaceutical company developing innovative microbiome-based therapeutics for the treatment of immune-mediated and infectious diseases, with specific focus on Immuno-Oncology and GI related disorders. Biomica’s discovery and development efforts are powered by PRISM (Predictive, high Resolution, Integrative Selection of Microbes) platform. Employing a holistic approach, PRISM combines a profound understanding of the microbiome and its functions and their intricate relations with the human host.